Skip to content
TrialScanner

NCT05818553

A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)

Phase 2/Phase 3Active, not recruitingPRAXLead

Registry record

Lead sponsor
Praxis Precision Medicines
Conditions
SCN2A Encephalopathy; SCN8A Encephalopathy
Primary completion
Nov 12, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05818553 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT05818553: A Clinical Trial of PRAX-562... | TrialScanner